Search

Author/Creator Hitschold, Thomas

1. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020)

Authors:
Pfisterer, Jacobus; Shannon, Catherine M; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P; Hein, Alexander; Zeimet, Alain G; Hanker, Lars C; Petit, Thierry; Marmé, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 5(2020)
Page Start:
699
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study. (December 2022)

Authors:
Reinisch, Mattea; Untch, Michael; Mahlberg, Rolf; Reimer, Toralf; Hitschold, Thomas; Marmé, Frederik; Aydogdu, Mustafa; Schmatloch, Sabine; Lück, Hans-Joachim; Schmidt, Marcus; Ladda, Ekkehart; Sinn, Bruno Valentin; Klare, Peter; Janni, Wolfgang; Jackisch, Christian; Denkert, Carsten; Seiler, Sab...
Journal:
Breast
Issue:
Volume 66(2022)
Page Start:
110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search